Lancet 402 , 670671 (2023)
Healthcare professionals usually recommend starting with a lower dose and gradually increasing it
The semaglutide side effect profile and tirzepatide side effect profile differ in important ways, even though both are GLP-1 agonists
The distinction sounds academic until you consider what it means for appetite suppression, muscle preservation, metabolic adaptation, and long-term outcomes
While most patients tolerate semaglutide well, individualized monitoring and dose adjustments may be necessary to optimize both efficacy and tolerability throughout the treatment course
Ofrecen resultados importantes, pero tambin son invasivos, requieren una recuperacin prolongada y conllevan ms riesgos